SCHEMBL5042258

SCHEMBL5042258

COc1ccc2cc(-c3ccc(C(=O)O)cc3)ccc2c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.74
RXRA P19793 1/20 0.67
CA1 P00915 1/20 0.63
CA2 P00918 1/20 0.63
RARA P10276 2/20 0.59
RARB P10826 2/20 0.59
RARG P13631 2/20 0.59
HSD17B1 P14061 2/20 0.58
HSD17B2 P37059 2/20 0.58
PLAU P00749 2/20 0.57
CHEK1 O14757 1/20 0.56
CYP11B1 P15538 3/20 0.56
CYP11B2 P19099 3/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
NR4A2 P43354 1/20 0.55
PLG P00747 1/20 0.55
PLAT P00750 1/20 0.55
GSTP1 P09211 1/20 0.54
HSD17B10 Q99714 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5047379 0.90 KDM4E (0.74) KDM4ERXRACA1CA2RARA
SCHEMBL14284927 0.86 CYP11B1 (0.68) KDM4EHSD17B1HSD17B2PLAUCYP11B1
SCHEMBL8132 0.85 KDM4E (1.00) KDM4ERXRACA1CA2RARA
SCHEMBL34463427 0.85 KDM4E (1.00) KDM4ERXRACA1CA2RARA
SCHEMBL3008341 0.85 HSD17B1 (0.72) KDM4ERXRAHSD17B1HSD17B2CYP11B1
SCHEMBL2043183 0.85 CA1 (0.87) KDM4ERXRACA1CA2CHEK1
SCHEMBL15897010 0.85 CYP11B1 (0.69) KDM4ECA1CA2HSD17B1HSD17B2
SCHEMBL9702751 0.84 KDM4E (0.77) KDM4ERXRACA1CA2CYP1A2
Hydrochloric Acid SCHEMBL3541422 0.84 KDM4E (0.96) KDM4ERXRACA1CA2RARA
SCHEMBL5875335 0.84 KDM4E (0.96) KDM4ERXRACA1CA2RARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5124473-A Skin disorders; antiinflammatory agents, antiallergens CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1992-06-23 US claimed
EP-0210929-B1 AROMATIC POLYCYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL AND COSMETIC USE CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA - CIRD GALDERMA (FR) 1992-06-03 EP claimed
US-7317066-B2 Liquid crystal polymers RENSSELAER POLYTECHNIC INSTITUTE (US) 2008-01-08 US disclosed
US-7317066-B2 Liquid crystal polymers RENSSELAER POLYTECHNIC INSTITUTE (US) 2008-01-08 US disclosed
US-7317066-B2 Liquid crystal polymers RENSSELAER POLYTECHNIC INSTITUTE (US) 2008-01-08 US disclosed
US-20060293490-A1 Liquid crystal polymers BENICEWICZ BRIAN 2006-12-28 US disclosed
US-7148311-B2 Liquid crystal polymers RENSSELAER POLYTECHNIC INSTITUTE (US) 2006-12-12 US disclosed
US-20050197483-A1 Liquid crystal polymers RENSSELAER POLYTECHNIC INSTITUTE (US) 2005-09-08 US disclosed
WO-2004016673-A1 LIQUID CRYSTAL POLYMERS RENSSELAER POLYTECHNIC INSTITUTE (US) 2004-02-26 WO disclosed
US-5686586-A Polycyclic aromatic derivatives, process for preparing the same and pharmaceutical and cosmetic compositions containing the same CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1997-11-11 US disclosed
US-5602104-A SKIN DISORDERS, CONJUNCTIVE TISSUE DISORDERS, ANTITUMOR AGENTS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1997-02-11 US disclosed
US-5434180-A Skin disorders; retinoid activity; rheumatoid psoriasis; CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1995-07-18 US disclosed
US-5124473-A Skin disorders; antiinflammatory agents, antiallergens CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1992-06-23 US disclosed